bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
The COVID-19 pandemic poses a threat to our antibiotic infrastructure, which is already compromised due to a lack of new therapies. That threat makes antimicrobial stewardship even more important.
Patients at the greatest risk for secondary infections, particularly infections that are resistant to first-line antibiotics, include people who are already vulnerable due to other conditions and diseases—like COVID-19. Because of that, antimicrobial resistance poses a significant additional threat, especially as healthcare systems become overburdened.
Researchers from MIT and Harvard developed a new approach to antibiotic discovery using a type of artificial AI called deep learning. So far, their model has identified eight antibacterial compounds that differ in structure from known antibiotics.
Infections are the leading cause of death in patients with extensive burn injuries, with studies showing 42%-65% of burn deaths attributable to infection.
Amid the spread of COVID-19, testing for SARS-COV-2, the virus...
Patients at the greatest risk for secondary infections, particularly infections...